Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled,Multi-Centre Trial of the Efficacy and Safety of the Occlutech Septal Occluder(Figulla Flex II) Compared to the AGA Septal Occluder(Amplatzer ASO) for Transcatheter Closure of Secundum ASD in Patients

NCT04488120 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.

NCT NCT04488120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04488120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled,Multi-Centre Trial of the Efficacy and Safety of the Occlutech Septal Occluder(Figulla Flex II) Compared to the AGA Septal Occluder(Amplatzer ASO) for Transcatheter Closure of Secundum ASD in Patients
Lead sponsor
Occlutech International AB
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2012
Completion date
October 31, 2017
Enrollment
175 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

secundum atrial septal defects